Looking at HIN presentation at the Oppenheimer healthcare...

Looking at HIN presentation at the Oppenheimer healthcare conference in New York last week. The more you hear and read about this stock the more convinced l become for a strong growth future.

A few stats--- over 1500 implants now, over 320 employees, sales are ramping with Germany currently the largest market with 42%, USA 31%, ROW 27%. Annual sales approx $80 mill.

They expect that post approval USA sales will ramp up quickly.

Regards FDA approval Godshall stated they have very regular communication with FDA but no indication of timeframe. The tone was sooner rather than later.

There's a webcast avaiable through their US website and takes around 30 minutes.